Work

Cost of treatment change among patients with neuroendocrine tumors (NET) treated originally with somatostatin analogs.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.3_suppl.365

Authors: Bernard Tawfik, David Ray, Meghan Moynihan, Nicole Princic

Institutions: UNM Comprehensive Cancer Center, Ipsen (United States), IBM (United States)

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Ipsen Biopharmaceuticals

OpenAlex ID: W3121490811

Cites:

Cited by: 1

Related to: 10